CXCL6 promotes human hepatocyte proliferation through the CXCR1-NFκB pathway and inhibits collagen i secretion by hepatic stellate cells

Biochemistry and Cell Biology

Volumn 94, Issue 3, 2016, Pages 229-235

  Li, Zhenghong ^a   Zhang, Qidi ^a   Zhang, Qingqing ^a   Xu, Mingyi ^a   Qu, Ying ^a   Cai, Xiaobo ^a   Lu, Lungen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

COLI; CXCL6; Hepatic stellate cells; Hepatocyte; Proliferation

Indexed keywords

AMINO ACIDS; BODY FLUIDS; CELLS; COLLAGEN; PHYSIOLOGY;

COLI; CXCL6; HEPATIC STELLATE CELLS; HEPATOCYTES; PROLIFERATION;

CYTOLOGY;

ASPARTATE AMINOTRANSFERASE; CHEMOKINE RECEPTOR CXCR1; COLLAGEN TYPE 1; GRANULOCYTE CHEMOTACTIC PROTEIN 2; I KAPPA B; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SMALL INTERFERING RNA; CXCL6 PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL PROLIFERATION; CHRONIC HEPATITIS B; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; IN VITRO STUDY; LIVER CELL; MALE; MIDDLE AGED; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; STELLATE CELL; UPREGULATION; CELL LINE; CYTOLOGY; GENETICS; HEPATIC STELLATE CELL; METABOLISM; PATHOLOGY; SECRETION (PROCESS);

ADULT; CELL LINE; CELL PROLIFERATION; CHEMOKINE CXCL6; COLLAGEN TYPE I; FEMALE; HEPATIC STELLATE CELLS; HEPATITIS B, CHRONIC; HEPATOCYTES; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; NF-KAPPA B; RECEPTORS, INTERLEUKIN-8A;

EID: 84973912603     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/bcb-2015-0136     Document Type: Article

References (17)

1. Asselah T. Bièche I. Laurendeau I. Paradis V. Vidaud D. Degott C. et al 2005. Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology, 129 (6): 2064-2075. 10.1053/j.gastro.2005.09.010. 16344072.
2. Cao X. Zhang W. Wan T. He L. Chen T. Yuan Z. et al 2000. Molecular cloning and characterization of a novel CXC chemokine macrophage inflammatory protein-2 chemoattractant for human neutrophils and dendritic cells. J. Immunol. 165 (5): 2588-2595. 10.4049/jimmunol.165.5.2588. 10946286.
3. Clarke C.N. Kuboki S. Tevar A. Lentsch A.B. Edwards M. 2009. CXC chemokines play a critical role in liver injury, recovery, and regeneration. Am. J. Surg. 198 (3): 415-419. 10.1016/j.amjsurg.2009.01.025. 19716886.
4. Clarke C. Kuboki S. Sakai N. Kasten K.R. Tevar A.M. Schuster R. et al 2011. CXC chemokine receptor-1 is expressed by hepatocytes and regulates liver recovery after hepatic ischemia/reperfusion injury. Hepatology, 53 (1): 261-271. 10.1002/hep.24028. 21254176.
5. Colletti L.M. Green M. Burdick M.D. Kunkel S.L. Strieter R.M. 1998. Proliferative effects of CXC chemokines in rat hepatocytes in vitro and in vivo. Shock, 10 (4): 248-257. 10.1097/00024382-199810000-00004. 9788656.
6. Iimuro Y. Nishio T. Morimoto T. Nitta T. Stefanovic B. Kyu S. et al 2003. Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology, 124 (2): 445-458. 10.1053/gast.2003.50063. 12557150.
7. Issa R. Zhou X. Trim N. Millward-Sadler H. Krane S. Benyon C. Iredale J. 2003. Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration. FASEB, J. 17 (1): 47-49. 12475903.
8. Kuboki S. Shin T. Huber N. Eismann T. Galloway E. Schuster R. et al 2008. Hepatocyte signaling through CXC chemokine receptor-2 is detrimental to liver recovery after ischemia/reperfusion in mice. Hepatology, 48 (4): 1213-1223. 10.1002/hep.22471.
9. 4 axis induces epithelial-mesenchymal transition in hepatocellular carcinoma. Mol. Cell. Biochem. 392 (1-2): 77-84. 10.1007/s11010-014-2020-8. 24658853.
10. Luedde T. Trautwein C. 2006. Intracellular survival pathways in the liver. Liver. Int. 26 (10): 1163-1174. 10.1111/j.1478-3231.2006.01366.x. 17105581.
11. Mantovani A. Bonecchi R. Locati M. 2006. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat. Rev. Immunol. 6 (12): 907-918. 10.1038/nri1964. 17124512.
12. Murphy P.M. 2002. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol. Rev. 54 (2): 227-229. 12037138.
13. Oyanagi J. Kojima N. Sato H. Higashi S. Kikuchi K. Sakai K. et al 2014. Inhibition of transforming growth factor-β signaling potentiates tumor cell invasion into collagen matrix induced by fibroblast-derived hepatocyte growth factor. Exp. Cell. Res. 326 (2): 267-279. 10.1016/j.yexcr.2014.04.009. 24780821.
14. Ren X. Carpenter A. Hogaboam C. Colletti L. 2003. Mitogenic properties of endogenous and pharmacological doses of macrophage inflammatory protein-2 after 70% hepatectomy in the mouse. Am. J. Pathol. 163 (2): 563-570. 10.1016/S0002-9440(10)63684-X. 12875976.
15. Scheuer P.J. 1995. The nomenclature of chronic hepatitis: time for a change. Hepatology, 22 (1): 112-114. 10.1016/0270-9139(95)90361-5. 7751577.
16. Taub R. 2004. Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell. Biol. 5 (10): 836-847. 10.1038/nrm1489. 15459664.
17. Terui K. Ozaki M. 2005. The role of STAT3 in liver regeneration. Drugs. Today 41 (7): 461-469. 10.1358/dot.2005.41.7.893622. 16193099.